Oshadi Icp

DRUG2 trials

Sponsors

Oshadi Drug Administration

Conditions

Diabetes MellitusDiabetes Mellitus, Insulin-Dependent, 1Insulin-DependentType 1

Phase 1

Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study

CompletedNCT01772251

Oshadi Drug AdministrationDiabetes Mellitus, Insulin-Dependent, 1

Start: 2013-02-28End: 2013-06-30Updated: 2013-10-29

Phase 2

Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study

CompletedNCT01973920

Oshadi Drug AdministrationDiabetes Mellitus, Insulin-Dependent, Type 1

Start: 2013-12-31End: 2017-02-28Updated: 2018-04-18